Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros

Base de dados
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Bioorg Med Chem Lett ; 22(12): 4028-32, 2012 Jun 15.
Artigo em Inglês | MEDLINE | ID: mdl-22579486
2.
Org Lett ; 14(15): 3906-8, 2012 Aug 03.
Artigo em Inglês | MEDLINE | ID: mdl-22809236

RESUMO

A simple, novel, and efficient route for the synthesis of 5-amino-3-aryl-1-(tert-butyl)-1H-pyrazole-4-carboxamides 1 has been devised. Preparation of pyrazole bromide 3 from potassium tricyanomethanide can be accomplished in only two steps in good yield and features a selective Sandmeyer reaction on the corresponding diaminopyrazole. This allows for a more versatile synthesis of 5-amino-3-aryl-1-(tert-butyl)-1H-pyrazole-4-carboxamides 1 than was previously possible.


Assuntos
Amidas/síntese química , Hidrocarbonetos Bromados/síntese química , Pirazóis/síntese química , Amidas/química , Técnicas de Química Combinatória , Hidrocarbonetos Bromados/química , Estrutura Molecular , Pirazóis/química , Estereoisomerismo
3.
J Med Chem ; 54(6): 1871-95, 2011 Mar 24.
Artigo em Inglês | MEDLINE | ID: mdl-21341675

RESUMO

Phosphoinositide-dependent protein kinase-1(PDK1) is a master regulator of the AGC family of kinases and an integral component of the PI3K/AKT/mTOR pathway. As this pathway is among the most commonly deregulated across all cancers, a selective inhibitor of PDK1 might have utility as an anticancer agent. Herein we describe our lead optimization of compound 1 toward highly potent and selective PDK1 inhibitors via a structure-based design strategy. The most potent and selective inhibitors demonstrated submicromolar activity as measured by inhibition of phosphorylation of PDK1 substrates as well as antiproliferative activity against a subset of AML cell lines. In addition, reduction of phosphorylation of PDK1 substrates was demonstrated in vivo in mice bearing OCl-AML2 xenografts. These observations demonstrate the utility of these molecules as tools to further delineate the biology of PDK1 and the potential pharmacological uses of a PDK1 inhibitor.


Assuntos
Antineoplásicos/síntese química , Indazóis/síntese química , Morfolinas/síntese química , Piperidinas/síntese química , Proteínas Serina-Treonina Quinases/antagonistas & inibidores , Pirimidinas/síntese química , Animais , Antineoplásicos/química , Antineoplásicos/farmacologia , Linhagem Celular Tumoral , Cristalografia por Raios X , Ensaios de Seleção de Medicamentos Antitumorais , Indazóis/química , Indazóis/farmacologia , Camundongos , Camundongos SCID , Modelos Moleculares , Estrutura Molecular , Morfolinas/química , Morfolinas/farmacologia , Transplante de Neoplasias , Fosforilação , Piperidinas/química , Piperidinas/farmacologia , Ligação Proteica , Pirimidinas/química , Pirimidinas/farmacologia , Piruvato Desidrogenase Quinase de Transferência de Acetil , Estereoisomerismo , Relação Estrutura-Atividade , Transplante Heterólogo
4.
Bioorg Med Chem ; 10(3): 731-6, 2002 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-11814862

RESUMO

A series of conformationally-restricted analogues of hPTH was prepared, based on the parent peptide agonist, cyclo(Lys(18)-Asp(22))[Ala(1),Nle(8),Lys(18),Asp(22),Leu(27)]hPTH(1-31)NH(2) (2, EC(50)=0.29nM). Truncation of 2 at either the N- or C-termini resulted in peptides with reduced agonist activity as measured by stimulation of adenylate cyclase activity in the rat osteosarcoma cell line (ROS 17/2.8). Alanine- and glycine-scanning at the N-terminus of 2 was consistent with data previously obtained on linear hPTH(1-34). Other locations within the primary sequence of hPTH(1-31)NH(2) were evaluated by the placement of the [i, i+4] lactam constraining element. Ring size and lactam orientations at the 18-22 positions were also examined.


Assuntos
Hormônio Paratireóideo/química , Fragmentos de Peptídeos/química , Adenilil Ciclases/efeitos dos fármacos , Sequência de Aminoácidos , Animais , Humanos , Lactamas/química , Dados de Sequência Molecular , Hormônio Paratireóideo/genética , Hormônio Paratireóideo/farmacologia , Fragmentos de Peptídeos/genética , Fragmentos de Peptídeos/farmacologia , Ligação Proteica , Conformação Proteica , Engenharia de Proteínas , Ratos , Receptores de Hormônios Paratireóideos/agonistas , Relação Estrutura-Atividade , Células Tumorais Cultivadas
5.
Bioorg Med Chem Lett ; 12(9): 1303-6, 2002 May 06.
Artigo em Inglês | MEDLINE | ID: mdl-11965376

RESUMO

A narrow structure-activity relationship was established for the 4-aryl group in 4-aryl-pyridine glucagon antagonists, with only small substituents being well-tolerated, and only at the 3'- and 4'-positions. However, substitution with a 2'-hydroxy group gave a ca. 3-fold increase in activity (e.g., 4'-fluoro-2'-hydroxy analogue 33, IC50=190 nM). For efficient preparation of 2'-substituted phenylpyridines, a novel synthesis via pyrones and 4-methoxy-pyridines was developed.


Assuntos
Glucagon/antagonistas & inibidores , Piridinas/síntese química , Piridinas/farmacologia , Piridinas/química , Relação Estrutura-Atividade
6.
Bioorg Med Chem Lett ; 13(8): 1415-8, 2003 Apr 17.
Artigo em Inglês | MEDLINE | ID: mdl-12668002

RESUMO

The discovery of novel 5,7-disubstituted[1,6]naphthyridines as potent inhibitors of Spleen Tyrosine Kinase (SYK) is discussed. The SAR reveals the necessity for a 7-aryl group with preference towards para substitution and that this in combination with 5-aminoalkylamino substituents further improved the potency of the compounds. The initial SAR as well as a survey of the other positions is discussed in detail.


Assuntos
Inibidores Enzimáticos/química , Inibidores Enzimáticos/farmacologia , Precursores Enzimáticos/antagonistas & inibidores , Naftiridinas/química , Naftiridinas/farmacologia , Proteínas Tirosina Quinases/antagonistas & inibidores , Baço/enzimologia , Animais , Humanos , Concentração Inibidora 50 , Peptídeos e Proteínas de Sinalização Intracelular , Relação Estrutura-Atividade , Quinase Syk
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA